Skip to main content
62°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
I-Mab ADR
(NQ:
IMAB
)
1.215
+0.015 (+1.25%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about I-Mab ADR
< Previous
1
2
3
4
5
6
Next >
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 04, 2024
Via
Benzinga
(IMAB) - Analyzing I-MAB's Short Interest
May 07, 2024
Via
Benzinga
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
March 18, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Looking Into I-MAB's Recent Short Interest
February 07, 2024
Via
Benzinga
Expert Ratings for I-MAB
September 25, 2023
Via
Benzinga
Where I-MAB Stands With Analysts
September 05, 2023
Via
Benzinga
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...
Via
Talk Markets
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Analyst Ratings for I-MAB
August 18, 2023
Via
Benzinga
5 Analysts Have This to Say About I-MAB
June 05, 2023
Via
Benzinga
I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment
May 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 28, 2023
We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories!
Via
InvestorPlace
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet...
Via
Talk Markets
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.
Via
InvestorPlace
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
April 25, 2023
TRACON Pharmaceuticals (TCON) stock is falling on Tuesday morning following an update on a legal battle with I-Mab (IMAB).
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 25, 2023
It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday!
Via
InvestorPlace
Last Day Of Q1
March 31, 2023
Wall Street bonuses fell 26% last year. This was the biggest drop since 2008. Wall Street is estimated to be responsible for 16% of all economic activity in NYC. Wild nights out for ibankers slowing...
Via
Benzinga
ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash
March 31, 2023
Key Takeaways: ImmuneOnco’s main product pipeline is a cancer drug targeting a promising protein pathway, the first such drug to enter clinical tests in China, with more intensive trials due in the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 06, 2023
Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 06, 2023
Via
Benzinga
Energizer, Children's Place And Other Big Stocks Moving Lower On Monday
February 06, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday
January 30, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
January 12, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.